Head of Global Business Development and M&A, Nestlé Health Science
Founder of Biosynex SA, Dectra Pharm SAS and All Diag
Peter Westlake is responsible for commercial, financial and operational activities at ProciseDx. As CFO of Prometheus Laboratories from 2011 to 2019, Peter built operational and transaction experience in diagnostics and pharmaceuticals, with multiple product launches, and leading diverse acquisitions and disposals.
Dr. Mimms is currently CEO of ProciseDx in San Diego. He was Chief Scientific Officer at Prometheus Laboratories (2015 to 2019). From 2009 to 2015, Dr. Mimms served as Vice President R&D Quidel Corp., a world leader in development of point of care, rapid tests.
Head of Global Business Development and M&A, Nestlé Health Science
Founder of Biosynex SA, Dectra Pharm SAS and All Diag
Peter Westlake is responsible for commercial, financial and operational activities at ProciseDx. As CFO of Prometheus Laboratories from 2011 to 2019, Peter built operational and transaction experience in diagnostics and pharmaceuticals, with multiple product launches, and leading diverse acquisitions and disposals.
Director of Enterome.
Director of Enterome.
Director of Enterome.
Director of Enterome.
Director of Enterome.
Chairman of the Board in Enterome.
Director of Enterome.
Director of Enterome.
Director of Enterome.
Director of Enterome.